Skip to main content
SpringerLink
Log in

Umbilical Cord Stem Cells in the Treatment of Corneal Diseases

  • Chapter
  • First Online:
Corneal Regeneration

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 924 Accesses

Abstract

To restore transparency and function, corneal specialists currently utilise stem cells of different origins, bioengineered cells and biomaterials. Stem cells are capable of giving rise to progenies with specific functional and morphological traits and in recent years, extraordinary advances have initiated an era of hope for clinical regenerative strategies and tissue engineering applications. In this chapter, we provide an overview of the potential benefits of human umbilical cord derived stem cell therapy and briefly review current approaches to utilize human umbilical cord stem cells to treat diseases involving the corneal epithelium, stroma, and endothelium.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Oliva MS, Schottman T, Gulati M. Turning the tide of corneal blindness. Indian J Ophthalmol. 2012;60(5):423–7.

    Article  Google Scholar 

  2. Weiss ML, Troyer DL. Stem cells in the umbilical cord. Stem Cell Rev. 2006;2(2):155–62.

    Article  CAS  Google Scholar 

  3. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282(5391):1145–7.

    Article  CAS  Google Scholar 

  4. Takacs L, Toth E, Berta A, Vereb G. Stem cells of the adult cornea: from cytometric markers to therapeutic applications. Cytometry A. 2009;75(1):54–66.

    Article  Google Scholar 

  5. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–72.

    Article  CAS  Google Scholar 

  6. Arutyunyan I, Elchaninov A, Makarov A, Fatkhudinov T. Umbilical cord as prospective source for mesenchymal stem cell-based therapy. Stem Cells Int. 2016;2016:6901286.

    Article  Google Scholar 

  7. Ziaei M, Zhang J, Patel DV, McGhee CNJ. Umbilical cord stem cells in the treatment of corneal disease. Surv Ophthalmol. 2017;62(6):803–15.

    Article  Google Scholar 

  8. Chang YJ, Tseng CP, Hsu LF, Hsieh TB, Hwang SM. Characterization of two populations of mesenchymal progenitor cells in umbilical cord blood. Cell Biol Int. 2006;30(6):495–9.

    Article  CAS  Google Scholar 

  9. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25(11):2739–49.

    Article  CAS  Google Scholar 

  10. Oie Y, Nishida K. Regenerative medicine for the cornea. Biomed Res Int. 2013;2013:428247.

    Article  Google Scholar 

  11. Dua HS, Forrester JV. The corneoscleral limbus in human corneal epithelial wound healing. Am J Ophthalmol. 1990;110(6):646–56.

    Article  CAS  Google Scholar 

  12. Shortt AJ, Tuft SJ, Daniels JT. Corneal stem cells in the eye clinic. Br Med Bull. 2011;100:209–25.

    Article  Google Scholar 

  13. Bobba S, Di Girolamo N, Mills R, Daniell M, Chan E, Harkin DG, et al. Nature and incidence of severe limbal stem cell deficiency in Australia and New Zealand. Clin Exp Ophthalmol. 2017;45(2):174–81.

    Article  Google Scholar 

  14. Reza HM, Ng BY, Phan TT, Tan DT, Beuerman RW, Ang LP. Characterization of a novel umbilical cord lining cell with CD227 positivity and unique pattern of P63 expression and function. Stem Cell Rev. 2011;7(3):624–38.

    Article  CAS  Google Scholar 

  15. Wang J, Hao J, Bai D, Gu Q, Han W, Wang L, et al. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions. Stem Cell Res Ther. 2015;6:223.

    Article  Google Scholar 

  16. DelMonte DW, Kim T. Anatomy and physiology of the cornea. J Cataract Refract Surg. 2011;37(3):588–98.

    Article  Google Scholar 

  17. Coulson-Thomas VJ, Caterson B, Kao WW. Transplantation of human umbilical mesenchymal stem cells cures the corneal defects of mucopolysaccharidosis VII mice. Stem Cells. 2013;31(10):2116–26.

    Article  CAS  Google Scholar 

  18. Kao WW, Call M, Chang S-H, Birk DE. Human umbilical mesenchymal stem cells treat acquired and congenital corneal opacity. Invest Ophthalmol Vis Sci. 2015;56:1304.

    Article  Google Scholar 

  19. Coulson-Thomas VJ, Gesteira TF, Hascall V, Kao W. Umbilical cord mesenchymal stem cells suppress host rejection: the role of the glycocalyx. J Biol Chem. 2014;289(34):23465–81.

    Article  CAS  Google Scholar 

  20. Joyce NC. Proliferative capacity of the corneal endothelium. Prog Retin Eye Res. 2003;22(3):359–89.

    Article  CAS  Google Scholar 

  21. Joyce NC. Proliferative capacity of corneal endothelial cells. Exp Eye Res. 2012;95(1):16–23.

    Article  CAS  Google Scholar 

  22. Cvekl A, Tamm ER. Anterior eye development and ocular mesenchyme: new insights from mouse models and human diseases. BioEssays. 2004;26(4):374–86.

    Article  CAS  Google Scholar 

  23. Joyce NC, Harris DL, Markov V, Zhang Z, Saitta B. Potential of human umbilical cord blood mesenchymal stem cells to heal damaged corneal endothelium. Mol Vis. 2012;18:547–64.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Shao C, Chen J, Chen P, Zhu M, Yao Q, Gu P, et al. Targeted transplantation of human umbilical cord blood endothelial progenitor cells with immunomagnetic nanoparticles to repair corneal endothelium defect. Stem Cells Dev. 2015;24(6):756–67.

    Article  CAS  Google Scholar 

  25. Park CY, Lee JK, Gore PK, Lim CY, Chuck RS. Keratoplasty in the United States: a 10-year review from 2005 through 2014. Ophthalmology. 2015;122(12):2432–42.

    Article  Google Scholar 

  26. Ittner LM, Wurdak H, Schwerdtfeger K, Kunz T, Ille F, Leveen P, et al. Compound developmental eye disorders following inactivation of TGFbeta signaling in neural-crest stem cells. J Biol. 2005;4(3):11.

    Article  Google Scholar 

  27. Proulx S, Brunette I. Methods being developed for preparation, delivery and transplantation of a tissue-engineered corneal endothelium. Exp Eye Res. 2012;95(1):68–75.

    Article  CAS  Google Scholar 

  28. Chen Y, Huang K, Nakatsu MN, Xue Z, Deng SX, Fan G. Identification of novel molecular markers through transcriptomic analysis in human fetal and adult corneal endothelial cells. Hum Mol Genet. 2013;22(7):1271–9.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, New Zealand National Eye Centre, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand

    Mohammed Ziaei, Jie Zhang, Dipika V. Patel & Charles N. J. McGhee

Authors
  1. Mohammed Ziaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jie Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dipika V. Patel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Charles N. J. McGhee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jie Zhang .

Editor information

Editors and Affiliations

  1. Miguel Hernández University , Alicante, Spain

    Jorge L. Alió

  2. Vissum-Instituto Oftalmologico de Alica, University Miguel Hernandez, Alicante, Alicante, Spain

    Jorge L. Alió del Barrio

  3. Vissum Corporation, Madrid, Spain

    Francisco Arnalich-Montiel

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ziaei, M., Zhang, J., Patel, D.V., McGhee, C.N.J. (2019). Umbilical Cord Stem Cells in the Treatment of Corneal Diseases. In: Alió, J., Alió del Barrio, J., Arnalich-Montiel, F. (eds) Corneal Regeneration . Essentials in Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-030-01304-2_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-01304-2_32

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-01303-5

  • Online ISBN: 978-3-030-01304-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation